{
    "ticker": "AGNCP",
    "name": "Allergan plc",
    "description": "Allergan plc is a global pharmaceutical company known for its commitment to developing innovative products that improve patient outcomes. Founded in 1948, the company has a rich history of producing a diverse range of medical and aesthetic products. Allergan specializes in various therapeutic areas, including ophthalmology, neurosciences, and medical aesthetics, with its flagship product being the widely recognized Botox, used for both cosmetic and therapeutic applications. The company's portfolio also includes treatments for eye care, dermatology, and central nervous system disorders, focusing on addressing unmet medical needs. Allergan operates with a mission to unleash the potential of biology and technology through groundbreaking research and development, fostering advancements in healthcare. The company is dedicated to sustainability and corporate responsibility, actively engaging in initiatives that contribute to community well-being and environmental stewardship. Allergan is recognized as a leader in the aesthetics market, continually innovating to enhance the patient experience and expand treatment options. With a global presence, Allergan strives to make a difference in people's lives by providing high-quality products and solutions that promote health and wellness.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Dublin, Ireland",
    "founded": "1948",
    "website": "https://www.allergan.com",
    "ceo": "Brent Saunders",
    "social_media": {
        "twitter": "https://twitter.com/Allergan",
        "linkedin": "https://www.linkedin.com/company/allergan/",
        "instagram": "https://www.instagram.com/allergan/"
    },
    "investor_relations": "https://investors.allergan.com",
    "key_executives": [
        {
            "name": "Brent Saunders",
            "position": "CEO"
        },
        {
            "name": "Matthew Walsh",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Aesthetics",
            "products": [
                "Botox",
                "Juvederm"
            ]
        },
        {
            "category": "Eye Care",
            "products": [
                "Restasis",
                "Lumify"
            ]
        },
        {
            "category": "Neuroscience",
            "products": [
                "Vraylar",
                "Namenda"
            ]
        }
    ],
    "seo": {
        "meta_title": "Allergan plc | Leading Pharmaceutical and Aesthetic Solutions",
        "meta_description": "Explore Allergan plc, a global leader in pharmaceuticals and medical aesthetics. Learn about their innovative products, commitment to patient care, and advancements in healthcare.",
        "keywords": [
            "Allergan",
            "Pharmaceuticals",
            "Medical Aesthetics",
            "Botox",
            "Eye Care",
            "Neuroscience"
        ]
    },
    "faq": [
        {
            "question": "What is Allergan known for?",
            "answer": "Allergan is known for its innovative products in medical aesthetics, eye care, and neuroscience, including Botox and Juvederm."
        },
        {
            "question": "Who is the CEO of Allergan?",
            "answer": "Brent Saunders is the CEO of Allergan plc."
        },
        {
            "question": "Where is Allergan headquartered?",
            "answer": "Allergan is headquartered in Dublin, Ireland."
        },
        {
            "question": "What are Allergan's main products?",
            "answer": "Allergan's main products include Botox, Juvederm, Restasis, and Vraylar."
        },
        {
            "question": "When was Allergan founded?",
            "answer": "Allergan was founded in 1948."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "BMY",
        "MRK"
    ],
    "related_stocks": [
        "ABT",
        "GILD",
        "AMGN",
        "REGN"
    ]
}